Abstract
The incidence of deep vein thrombosis has increased year by year in the world, and it has become one of the serious diseases that threaten human life. In severe cases, it can lead to fatal pulmonary embolism. The pathogenesis of deep vein thrombosis is the result of the interaction of multiple genetic environmental factors. Therefore, regulation of gene expression by modification of DNA and histones may help to further reveal the pathogenesis of deep vein thrombosis, and reactivation or silencing of some genes that are inhibited or overexpressed by aberrant methylation may be a major therapeutic target for deep vein thrombosis. The author reviews the current status of DNA methylation studies related to deep vein thrombosis. Key words: Venous thrombosis; Gene; DNA methylation; MicroRNAs
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
